Wellcome Trust Awards $2.7M for Alzheimer's Genome-Wide Association Study | GenomeWeb
NEW YORK (GenomeWeb News) – The UK’s Wellcome Trust said this week that it has awarded £1.3 million ($2.7 million) to support a large genome-wide association study with the goal of understanding the genetic basis of late-onset Alzheimer's disease.
 
Cardiff University will lead the project, which will analyze DNA samples from 14,000 people -- 6,000 with late-onset Alzheimer's disease and 8,000 controls from the UK and US.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.